Get a Telehealth Visit and Treatment for COVID-19

This service is available in all 50 states and Washington, D.C. AZOVA provides telehealth services through a network of licensed independent healthcare providers who have each received training in the appropriate use and prescribing of Emergency Use Authorized medications such as Paxlovid, standard prescription medications and vitamins and supplements that may assist in the recovery from COVID-19.

Your telemedicine provider can prescribe Emergency Use Authorized medications, standard prescription medications, and can also make recommendations for scientifically backed vitamins and supplements where appropriate.

Both Paxlovid (nirmatrelvir tablets; ritonavir tablets) and Molnupiravir are included in the Test-to-Treat program and are available through emergency use authorization (EUA) from the Food and Drug Administration (FDA). Here is the information about the Paxlovid EUA and the Fact Sheet for Patients. Here is the information about the Molnupiravir EUA and the Patient Fact Sheet. We will add new COVID-19 medications to our formulary as they become available.

Additional information on Paxlovid:

Paxlovid has not been approved, but has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARSCoV-2 viral testing, and who are at high-risk for progression to severe COVID-19, including hospitalization or death. The emergency use of Paxlovid is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.

Additional information on Molnupiravir:

Molnupiravir has not been approved, but has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults who are at high-risk for progression to severe COVID-19, including hospitalization or death, and for whom alternative COVID-19 treatment options authorized by FDA are not accessible or clinically appropriate. The emergency use of Molnupiravir is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization revoked sooner.

While the US government is covering the cost, Molnupiravir are free of charge. If your telehealth provider prescribes other medications, the cost can be calculated by the pharmacy before your purchase. Please note: The US government could choose to discontinue coverage of the Test-to-Treat medications at any time.

Telehealth services are only available for individuals 18 years of age or older and who have a symptomatic COVID-19 infection and who have a validated positive COVID-19 viral test report. If you would like your provider to prescribe Paxlovid, please note that you must also weigh at least 40 kg (88.18 lbs) with symptoms that began within the last 5 days and must have at least 1 high risk condition. If Paxlovid is not appropriate for you, your provider will make an alternate recommendation. All prescribing decisions are at the discretion of your telehealth provider.

Please refer to the Patient Fact Sheet for Paxlovid here.

Please refer to the Patient Fact Sheet for Molnupiravir here.

We do not offer refunds for the cost of telehealth services, medications or COVID test kits.

You will complete an online healthcare registration where we will ask you to answer questions about your health, medications and past medical history. We will ask for a photo of your government issued photo ID and any photos of relevant health conditions as appropriate. You will complete the registration and payment and, in most states, your information will be reviewed and you will receive an assessment and plan from your healthcare provider. In a few states, a video visit is required and you will be contacted for a video call with your healthcare provider.

Where appropriate, and as determined by your healthcare provider, you will receive a prescription for one of the Test to Treat medications. We will ship the medication to you or, if you see a healthcare provider in person, you can pick up your prescription locally.

You will receive a diagnosis and treatment plan within 24 hours or less from the time you complete your appointment registration.

Yes. You can purchase many different COVID tests here with or without video observation and telehealth proctoring services where you can also receive a validated laboratory report.

Yes. AZOVA is the leading provider of digital health networking technology and services. Our products and services enable governments, employers, health plans and individuals to access convenient healthcare services online and in person.

You can use an HSA or FSA card to pay for your telemedicine visit. You can also submit a claim to your insurance plan for the cost of a COVID test. The United States government is currently covering the cost of Molnupiravir so it is free of charge.